Shenzhen Neptunus Interlong Bio-technique Company Limited provided Group earnings guidance for the six-month ended 30 June 2018. The Group is expected to record a decrease of no more than 50% in the profit attributable to the owners of the Company for the six-month ended 30 June 2018 (the "Relevant Period"), as compared to the corresponding period in 2017. The decrease was mainly due to the substantial increase in the sales expenses and research and development costs of relevant subsidiaries, and the possible impact brought by the adoption of new accounting standards.